IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor ...

Imagine cells navigating through a complex maze, guided by chemical signals and the physical landscape of their environment.